Article

Human embryonic stem cell-derived vascular progenitor cells capable of endothelial and smooth muscle cell function.

Stem Cell Institute and Department of Medicine, University of Minnesota, Minneapolis, Minn. 55455, USA.
Experimental hematology (Impact Factor: 2.81). 03/2010; 38(3):246-257.e1. DOI: 10.1016/j.exphem.2010.01.001
Source: PubMed

ABSTRACT Previous studies have demonstrated development of endothelial cells (ECs) and smooth muscle cells (SMCs) as separate cell lineages derived from human embryonic stem cells (hESCs). We demonstrate CD34(+) cells isolated from differentiated hESCs function as vascular progenitor cells capable of producing both ECs and SMCs. These studies better define the developmental origin and reveal the relationship between these two cell types, as well as provide a more complete biological characterization.
hESCs are cocultured on M2-10B4 stromal cells or Wnt1-expressing M2-10B4 for 13 to 15 days to generate a CD34(+) cell population. These cells are isolated using a magnetic antibody separation kit and cultured on fibronectin-coated dishes in EC medium. To induce SMC differentiation, culture medium is changed and a morphological and phenotypic change occurs within 24 to 48 hours.
CD34(+) vascular progenitor cells give rise to ECs and SMCs. The two populations express respective cell-specific transcripts and proteins, exhibit intracellular calcium in response to various agonists, and form robust tube-like structures when cocultured in Matrigel. Human umbilical vein endothelial cells cultured under SMC conditions do not exhibit a change in phenotype or genotype. Wnt1-overexpressing stromal cells produced an increased number of progenitor cells.
The ability to generate large numbers of ECs and SMCs from a single vascular progenitor cell population is promising for therapeutic use to treat a variety of diseased and ischemic conditions. The stepwise differentiation outlined here is an efficient, reproducible method with potential for large-scale cultures suitable for clinical applications.

Download full-text

Full-text

Available from: Judy King, Oct 13, 2014
0 Followers
 · 
221 Views
  • Source
    • "Single spheres from day 21 to 26 were plated into 6 well culture dishes and cells were allowed to adhere and outgrow from the spheres in SKP medium for 48 hours. To obtain smooth muscle cells (SMCs), the medium was replaced with SMC differentiation medium consisting of high-glucose Dulbecco's modified Eagle medium (Invitrogen) containing 5% FBS, 5 ng/mL PDGF-BB (Invitrogen), and 2.5 ng/mL TGF-b1 (Invitrogen) as previously described (Hill et al., 2010). Medium was changed every 3 days. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Over the last decade, several adult stem cell populations have been identified in human skin (1-4). The isolation of multipotent adult dermal precursors was first reported by Miller F. D laboratory (5, 6). These early studies described a multipotent precursor cell population from adult mammalian dermis (5). These cells--termed SKPs, for skin-derived precursors-- were isolated and expanded from rodent and human skin and differentiated into both neural and mesodermal progeny, including cell types never found in skin, such as neurons (5). Immunocytochemical studies on cultured SKPs revealed that cells expressed vimentin and nestin, an intermediate filament protein expressed in neural and skeletal muscle precursors, in addition to fibronectin and multipotent stem cell markers (6). Until now, the adult stem cells population SKPs have been isolated from freshly collected mammalian skin biopsies. Recently, we have established and reported that a population of skin derived precursor cells could remain present in primary fibroblast cultures established from skin biopsies (7). The assumption that a few somatic stem cells might reside in primary fibroblast cultures at early population doublings was based upon the following observations: (1) SKPs and primary fibroblast cultures are derived from the dermis, and therefore a small number of SKP cells could remain present in primary dermal fibroblast cultures and (2) primary fibroblast cultures grown from frozen aliquots that have been subjected to unfavorable temperature during storage or transfer contained a small number of cells that remained viable (7). These rare cells were able to expand and could be passaged several times. This observation suggested that a small number of cells with high proliferation potency and resistance to stress were present in human fibroblast cultures (7). We took advantage of these findings to establish a protocol for rapid isolation of adult stem cells from primary fibroblast cultures that are readily available from tissue banks around the world (Figure 1). This method has important significance as it allows the isolation of precursor cells when skin samples are not accessible while fibroblast cultures may be available from tissue banks, thus, opening new opportunities to dissect the molecular mechanisms underlying rare genetic diseases as well as modeling diseases in a dish.
    Journal of Visualized Experiments 01/2013; DOI:10.3791/50185
  • Source
    • "Single spheres from day 21 to 26 were plated into 6 well culture dishes and cells were allowed to adhere and outgrow from the spheres in SKP medium for 48 hours. To obtain smooth muscle cells (SMCs), the medium was replaced with SMC differentiation medium consisting of high-glucose Dulbecco's modified Eagle medium (Invitrogen) containing 5% FBS, 5 ng/mL PDGF-BB (Invitrogen), and 2.5 ng/mL TGF-b1 (Invitrogen) as previously described (Hill et al., 2010). Medium was changed every 3 days. "
    [Show abstract] [Hide abstract]
    ABSTRACT: Hutchinson-Gilford progeria syndrome (HGPS, OMIM 176670) is a rare disorder characterized by segmental accelerated aging and early death from coronary artery disease or stroke. Nearly 90% of HGPS sufferers carry a G608G mutation within exon 11 of LMNA, producing a truncated form of prelamin A, referred to as "progerin". Here, we report the isolation of naïve multipotent skin-derived precursor (SKP) cells from dermal fibroblast cultures from HGPS donors. These cells form spheres and express the neural crest marker, nestin, in addition to the multipotent markers, OCT4, Sox2, Nanog and TG30; these cells can self-renew and differentiate into smooth muscle cells (SMCs) and fibroblasts. The SMCs derived from the HGPS-SKPs accumulate nuclear progerin with increasing passages. A subset of the HGPS-naïve SKPs express progerin in vitro and in situ in HGPS skin sections. This is the first in vivo evidence that progerin is produced in adult stem cells, and implies that this protein could induce stem cells exhaustion as a mechanism contributing to aging. Our study provides a basis on which to explore therapeutic applications for HGPS stem cells and opens avenues for investigating the pathogenesis of other genetic diseases.
    Biology Open 06/2012; 1(6):516-26. DOI:10.1242/bio.20121149 · 2.42 Impact Factor
  • Source
    • "Several different strategies have been explored to derive SMCs from hESCs. Progenitor cells such as CD34+ cells have been isolated either from spontaneously differentiated embryoid bodies (EBs) [Ferreira et al., 2007; Vazão et al., 2011] or from cocultures [Hill et al., 2010] and then further induced with factors such as TGF ␤ 1, PDGF-BB, retinoic acid, or a combination thereof to aid the differentiation into SMC-like cells. Others have utilized a combination of inductive cell culture medium along with extracellular matrix such as collagen IV [Vo et al., 2010] or Matrigel [Xie et al., 2007] to favor SMC differentiation . "
    [Show abstract] [Hide abstract]
    ABSTRACT: Despite substantial progress in the field of vascular tissue engineering over the past decades, transition to human models has been rather challenging. The limited replicative life spans of human adult vascular cells, and their slow rate of collagenous matrix production in vitro, have posed important hurdles in the development of mechanically robust and biologically functional engineered grafts. With the more recent advances in the field of stem cells, investigators now have access to a plethora of new cell source alternatives for vascular engineering. In this paper, we review various alternative cell sources made available more recently for blood vessel engineering and also present some recent data on the derivation of smooth muscle cells from human induced pluripotent stem cells.
    Cells Tissues Organs 01/2012; 195(1-2):15-25. DOI:10.1159/000331409 · 2.14 Impact Factor
Show more